SynthesisAnnals of family medicine

Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis.

Mark H Ebell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.